VEEV Stock Overview
Provides cloud-based software for the life sciences industry. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Veeva Systems Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$216.20 |
| 52 Week High | US$240.00 |
| 52 Week Low | US$157.55 |
| Beta | 0.83 |
| 1 Month Change | 4.75% |
| 3 Month Change | 12.90% |
| 1 Year Change | 26.14% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 36.63% |
Recent News & Updates
Recent updates
Shareholder Returns
| VEEV | AT Healthcare Services | AT Market | |
|---|---|---|---|
| 7D | -1.0% | -0.5% | -1.4% |
| 1Y | 26.1% | 11.1% | -1.6% |
Return vs Industry: VEEV exceeded the Austrian Healthcare Services industry which returned 11.2% over the past year.
Return vs Market: VEEV exceeded the Austrian Market which returned -1.6% over the past year.
Price Volatility
| VEEV volatility | |
|---|---|
| VEEV Average Weekly Movement | 5.6% |
| Healthcare Services Industry Average Movement | 6.1% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in AT Market | 6.2% |
| 10% least volatile stocks in AT Market | 2.1% |
Stable Share Price: VEEV's share price has been volatile over the past 3 months compared to the Austrian market.
Volatility Over Time: VEEV's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Austrian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 7,172 | Peter Gassner | www.veeva.com |
Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States. The company also provides Veeva Development Cloud, a suite of applications for the clinical, regulatory, quality, and safety functions, including Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality; Veeva QualityOne, a quality and document management, and training solution; Veeva RegulatoryOne, a solution that helps companies to manage regulatory submission content; and Veeva Claims addresses the end-to-end product and marketing claims management process.
Veeva Systems Inc. Fundamentals Summary
| VEEV fundamental statistics | |
|---|---|
| Market cap | €34.88b |
| Earnings (TTM) | €638.21m |
| Revenue (TTM) | €2.55b |
54.6x
P/E Ratio13.7x
P/S RatioIs VEEV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VEEV income statement (TTM) | |
|---|---|
| Revenue | US$2.66b |
| Cost of Revenue | US$692.57m |
| Gross Profit | US$1.96b |
| Other Expenses | US$1.30b |
| Earnings | US$665.91m |
Last Reported Earnings
Oct 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 4.10 |
| Gross Margin | 73.93% |
| Net Profit Margin | 25.07% |
| Debt/Equity Ratio | 0% |
How did VEEV perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 05:14 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/10/31 |
| Annual Earnings | 2024/01/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Veeva Systems Inc. is covered by 49 analysts. 31 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joseph Vruwink | Baird |
| Ishan Majumdar | Baptista Research |
| Saket Kalia | Barclays |